Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Oligonucleotide Ligation Assay (OLA) Resistance Study (OLA)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Seattle Children's Hospital
University of Nairobi
Information provided by (Responsible Party):
Michael Chung, University of Washington
ClinicalTrials.gov Identifier:
NCT01898754
First received: July 9, 2013
Last updated: October 24, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)